Interaction of SLC1A1 gene variants and life stress on pharmacological resistance in obsessive-compulsive disorder

E. Real, M. Gratacòs, J. Labad, P. Alonso, G. Escaramís, C. Segalàs, M. Subirà, C. López-Solà, X. Estivill, J. M. Menchón

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Genetic and environmental factors seem to interact and influence both the onset and the course of obsessive-compulsive disorder (OCD), but the role of glutamate transporter variants (SLC1A1) in pharmacological resistance is not known. We aimed to assess whether genetic variants in SLC1A1 and life stress at onset of the disorder interact and modulate pharmacological resistance in OCD. A single-marker association study of several single-nucleotide polymorphisms in the SLC1A1 genomic region was performed in a sample of 238 OCD patients. For the most strongly associated SNP (rs3087879), one copy of the risk allele increased the probability of higher treatment resistance (odds ratio=2.42; 95% confidence interval=1.39-4.21; P=0.0018), but only in OCD patients without life stress at onset of the disorder. These results suggest a gene-by-environment interaction effect on treatment resistance in OCD and strengthen the existing evidence of the role of the glutamatergic system in the phenomenology of OCD.

Original languageEnglish
Pages (from-to)470-475
Number of pages6
JournalPharmacogenomics Journal
Volume13
Issue number5
DOIs
Publication statusPublished - Oct 2013
Externally publishedYes

Fingerprint

Obsessive-Compulsive Disorder
Psychological Stress
Pharmacology
Genes
Single Nucleotide Polymorphism
Amino Acid Transport System X-AG
Gene-Environment Interaction
Alleles
Odds Ratio
Confidence Intervals
Therapeutics

Keywords

  • gene-by-environment interaction
  • genetics
  • life stress
  • obsessive-compulsive disorder
  • SLC1A1
  • treatment outcome

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine
  • Genetics

Cite this

Real, E., Gratacòs, M., Labad, J., Alonso, P., Escaramís, G., Segalàs, C., ... Menchón, J. M. (2013). Interaction of SLC1A1 gene variants and life stress on pharmacological resistance in obsessive-compulsive disorder. Pharmacogenomics Journal, 13(5), 470-475. https://doi.org/10.1038/tpj.2012.30

Interaction of SLC1A1 gene variants and life stress on pharmacological resistance in obsessive-compulsive disorder. / Real, E.; Gratacòs, M.; Labad, J.; Alonso, P.; Escaramís, G.; Segalàs, C.; Subirà, M.; López-Solà, C.; Estivill, X.; Menchón, J. M.

In: Pharmacogenomics Journal, Vol. 13, No. 5, 10.2013, p. 470-475.

Research output: Contribution to journalArticle

Real, E, Gratacòs, M, Labad, J, Alonso, P, Escaramís, G, Segalàs, C, Subirà, M, López-Solà, C, Estivill, X & Menchón, JM 2013, 'Interaction of SLC1A1 gene variants and life stress on pharmacological resistance in obsessive-compulsive disorder', Pharmacogenomics Journal, vol. 13, no. 5, pp. 470-475. https://doi.org/10.1038/tpj.2012.30
Real, E. ; Gratacòs, M. ; Labad, J. ; Alonso, P. ; Escaramís, G. ; Segalàs, C. ; Subirà, M. ; López-Solà, C. ; Estivill, X. ; Menchón, J. M. / Interaction of SLC1A1 gene variants and life stress on pharmacological resistance in obsessive-compulsive disorder. In: Pharmacogenomics Journal. 2013 ; Vol. 13, No. 5. pp. 470-475.
@article{476d56b93dc64a04996c5e0c53347b11,
title = "Interaction of SLC1A1 gene variants and life stress on pharmacological resistance in obsessive-compulsive disorder",
abstract = "Genetic and environmental factors seem to interact and influence both the onset and the course of obsessive-compulsive disorder (OCD), but the role of glutamate transporter variants (SLC1A1) in pharmacological resistance is not known. We aimed to assess whether genetic variants in SLC1A1 and life stress at onset of the disorder interact and modulate pharmacological resistance in OCD. A single-marker association study of several single-nucleotide polymorphisms in the SLC1A1 genomic region was performed in a sample of 238 OCD patients. For the most strongly associated SNP (rs3087879), one copy of the risk allele increased the probability of higher treatment resistance (odds ratio=2.42; 95{\%} confidence interval=1.39-4.21; P=0.0018), but only in OCD patients without life stress at onset of the disorder. These results suggest a gene-by-environment interaction effect on treatment resistance in OCD and strengthen the existing evidence of the role of the glutamatergic system in the phenomenology of OCD.",
keywords = "gene-by-environment interaction, genetics, life stress, obsessive-compulsive disorder, SLC1A1, treatment outcome",
author = "E. Real and M. Gratac{\`o}s and J. Labad and P. Alonso and G. Escaram{\'i}s and C. Segal{\`a}s and M. Subir{\`a} and C. L{\'o}pez-Sol{\`a} and X. Estivill and Mench{\'o}n, {J. M.}",
year = "2013",
month = "10",
doi = "10.1038/tpj.2012.30",
language = "English",
volume = "13",
pages = "470--475",
journal = "Pharmacogenomics Journal",
issn = "1470-269X",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Interaction of SLC1A1 gene variants and life stress on pharmacological resistance in obsessive-compulsive disorder

AU - Real, E.

AU - Gratacòs, M.

AU - Labad, J.

AU - Alonso, P.

AU - Escaramís, G.

AU - Segalàs, C.

AU - Subirà, M.

AU - López-Solà, C.

AU - Estivill, X.

AU - Menchón, J. M.

PY - 2013/10

Y1 - 2013/10

N2 - Genetic and environmental factors seem to interact and influence both the onset and the course of obsessive-compulsive disorder (OCD), but the role of glutamate transporter variants (SLC1A1) in pharmacological resistance is not known. We aimed to assess whether genetic variants in SLC1A1 and life stress at onset of the disorder interact and modulate pharmacological resistance in OCD. A single-marker association study of several single-nucleotide polymorphisms in the SLC1A1 genomic region was performed in a sample of 238 OCD patients. For the most strongly associated SNP (rs3087879), one copy of the risk allele increased the probability of higher treatment resistance (odds ratio=2.42; 95% confidence interval=1.39-4.21; P=0.0018), but only in OCD patients without life stress at onset of the disorder. These results suggest a gene-by-environment interaction effect on treatment resistance in OCD and strengthen the existing evidence of the role of the glutamatergic system in the phenomenology of OCD.

AB - Genetic and environmental factors seem to interact and influence both the onset and the course of obsessive-compulsive disorder (OCD), but the role of glutamate transporter variants (SLC1A1) in pharmacological resistance is not known. We aimed to assess whether genetic variants in SLC1A1 and life stress at onset of the disorder interact and modulate pharmacological resistance in OCD. A single-marker association study of several single-nucleotide polymorphisms in the SLC1A1 genomic region was performed in a sample of 238 OCD patients. For the most strongly associated SNP (rs3087879), one copy of the risk allele increased the probability of higher treatment resistance (odds ratio=2.42; 95% confidence interval=1.39-4.21; P=0.0018), but only in OCD patients without life stress at onset of the disorder. These results suggest a gene-by-environment interaction effect on treatment resistance in OCD and strengthen the existing evidence of the role of the glutamatergic system in the phenomenology of OCD.

KW - gene-by-environment interaction

KW - genetics

KW - life stress

KW - obsessive-compulsive disorder

KW - SLC1A1

KW - treatment outcome

UR - http://www.scopus.com/inward/record.url?scp=84884589842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884589842&partnerID=8YFLogxK

U2 - 10.1038/tpj.2012.30

DO - 10.1038/tpj.2012.30

M3 - Article

C2 - 22776887

AN - SCOPUS:84884589842

VL - 13

SP - 470

EP - 475

JO - Pharmacogenomics Journal

JF - Pharmacogenomics Journal

SN - 1470-269X

IS - 5

ER -